<DOC>
	<DOCNO>NCT00227214</DOCNO>
	<brief_summary>The aim study determine prevalence pneumococcal meningitis paediatric population Spain four year market Prevenar . Also secondary objective : 1 ) determine clinical characteristic outcome disease ; 2 ) determine serotypes antibiotic resistance pattern .</brief_summary>
	<brief_title>Study Evaluating Pneumococcal Meningitis Paediatric Population Spain Four Years After Marketing Prevenar .</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis , Pneumococcal</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>All child 0 14 year diagnosis confirm probable pneumococcal meningitis diagnosis suspect bacterial meningitis without bacterial viral isolation include study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>